News

Press Release

Researchers identify a novel player in acute myeloid leukemia

RNF5 is required for AML growth. The protein could be inhibited or used as a biomarker to improve patient outcomes.

Paper of the Week

The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors

Blog

Sanford Burnham Prebys drug enters Phase 1 study for the treatment of tobacco use disorder

A drug discovered in the lab of Nicholas Cosford, Ph.D., professor and deputy director of the NCI-designated Cancer Center at Sanford Burnham Prebys, has entered a Phase 1 clinical study.

Paper of the Week

Clinical evidence that a dysregulated master neural network modulator may aid in diagnosing schizophrenia

Blog

Advocates for our Cancer Center ensure patient perspective is understood in the lab

Spotlight: Helen Eckmann and Ruth Claire Black share a common history with breast cancer and a drive to serve their community.